Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · IEX Real-Time Price · USD

49.86

+1.93 (4.03%)

At close: Apr 26, 2024, 4:00 PM

51.25

+1.39 (2.79%)

After-hours: Apr 26, 2024, 7:59 PM EDT

Apellis Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	6,012	7,093	5,718	4,127	4,332	1,956	742	1,092
Market Cap Growth	-	24.06%	38.54%	-4.73%	121.45%	163.70%	-32.08%	-
Enterprise Value	5,771	6,852	5,278	3,635	3,831	1,761	593	943
PE Ratio	-13.42	-13.42	-8.77	-5.53	-12.56	-6.42	-5.82	-21.41
PS Ratio	15.16	17.89	75.81	62.01	17.28	-	-	-
PB Ratio	30.91	36.47	33.66	20.78	21.18	57.15	4.61	7.33
P/FCF Ratio	-11.91	-11.91	-11.10	-7.31	-26.11	-9.19	-5.65	-23.44
P/OCF Ratio	-11.93	-11.93	-11.13	-7.33	-26.99	-9.27	-5.65	-23.44
EV/Sales Ratio	14.55	17.28	69.97	54.62	15.28	-	-	-
EV/EBITDA Ratio	-13.84	-13.84	-8.55	-4.97	-12.27	-5.89	-4.74	-18.62
EV/EBIT Ratio	-13.79	-13.79	-8.53	-4.96	-12.24	-5.88	-4.74	-18.62
EV/FCF Ratio	-11.51	-11.51	-10.24	-6.44	-23.09	-8.28	-4.52	-20.24
Debt / Equity Ratio	0.57	0.57	0.66	1.06	1.85	4.59	0.17	0.18
Debt / EBITDA Ratio	-0.22	-0.22	-0.18	-0.29	-1.21	-0.53	-0.22	-0.52
Debt / FCF Ratio	-0.19	-0.19	-0.22	-0.37	-2.28	-0.74	-0.21	-0.57
Quick Ratio	2.26	2.26	3.35	5.40	6.85	5.35	10.35	26.80
Current Ratio	3.10	3.10	4.29	6.25	7.15	5.67	11.89	27.77
Asset Turnover	0.45	0.45	0.08	0.09	0.31	0	0	0
Interest Coverage	-16.80	-16.80	-18.97	-55.34	-10.46	-56.66	-49.74	-135.11
Return on Equity (ROE)	-178.50%	-178.50%	-204.80%	-5796.70%	-172.10%	-218.60%	-71.30%	-59.10%
Return on Assets (ROA)	-60.40%	-60.40%	-69.00%	-102.30%	-42.00%	-81.80%	-58.40%	-48.70%
Return on Capital (ROIC)	-169.30%	-169.30%	-210.42%	-131.16%	-36.70%	-150.59%	-68.04%	-29.04%
Earnings Yield	-8.79%	-7.45%	-11.41%	-18.08%	-7.96%	-15.58%	-17.19%	-4.67%
FCF Yield	-9.90%	-8.39%	-9.01%	-13.67%	-3.83%	-10.88%	-17.69%	-4.27%
Buyback Yield / Dilution	-11.84%	-11.84%	-25.70%	-12.32%	-20.78%	-14.40%	-292.16%	-64.57%
Total Shareholder Return	-11.84%	-11.84%	-25.70%	-12.32%	-20.78%	-14.40%	-292.16%	-64.57%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).